Delivery Order SPE2DB24D2208-SPE2DB25FHHDC

Award Date 2/7/25
Potential Completion Date 2/10/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,157.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract is for the delivery of Humalog 100 unit/mL KwikPen 3mL, a prescription insulin medication. There was no...
This federal contract award, valued at $1,024.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $1,388.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award, valued at $1,604.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 28, 2023. This contract award is not designated as a set-aside. AmerisourceBergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $1,024.32 firm fixed price delivery order is for the supply of Humalog 100 Unit/mL KwikPen, a brand name injectable insulin product, to support military treatment programs and facilities. The award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00...
This federal contract award, valued at $1,312.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of HUMALOG JR 100 UNIT/ML KWIKPEN 3ML, a diabetes medication. The award did not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,618.00 Firm Fixed Price delivery order is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a specialty insulin medication. The contract has an ultimate completion date of September 10, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,414.80 fixed-price contract is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a brand-name insulin product. The contract has an ultimate completion date of August 23, 2022 and was awarded on August 22, 2022. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award with award ID SPE2DX15D3020|SPE2DX24FXRST was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,374.13 firm-fixed-price contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. This delivery order contract has an ultimate completion date of August 1, 2024. Amerisourcebergen, the prime contractor, does not have any major subcontractors...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,024.32, is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a medication used to treat diabetes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued...
  • SPE2DB24D2208
    Indefinite Delivery Contract
  • SPE2DB24D2208-SPE2DB25FHHDC
    Delivery Order

This federal contract award, valued at $1,084.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication.

The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about major subcontractors. The DLA, as a defense agency, is responsible for providing logistics, acquisitions, and technical services to the U.S. military and other federal agencies.

Generated 5/9/25, 9:59 AM